eupolicy.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
This Mastodon server is a friendly and respectful discussion space for people working in areas related to EU policy. When you request to create an account, please tell us something about you.

Server stats:

223
active users

#RSV

0 posts0 participants0 posts today

Australian Influenza and RSV cases update:

Reported Influenza cases for Australia continued to rise for June, but at a steady pace. Whereas up to April cases were running at "flunami" pace, it now looks like either a lower or later peak than the recent "big" years: 2017, 2019, 2022, 2023 & 2024.

#Influenza #RSV #Australia @auscovid19
🧵

NEW: In surprise move, RFK Jr.'s vax committee votes to recommend RSV shot for infants.

RSV hospitalizes ~58K U.S. kids <5yo each yr; several hundred die. The panel—stacked with skeptics— backed Merck’s antibody 5–2. #RSV #Vaccines usatoday.com/story/news/health #press

USA TODAY · In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infantsBy , USA TODAY

#FYI #USA #MicrobeTV #TWiV #ThisWeekInVirology #DanielGriffin #VincentRacaniello #infectiousdiseases #mpox #measles #Ebola #covid19 #covid #sarscov2 #avianflu #birdflu #influenza #polio #RSV #vaccinate #vaccines

TWiV 1220: Clinical update week 24. May 2025

"changes in FDA vaccine approval policy especially how it is applied to COVID-19 vaccines and restricts vaccine availability/usage and Novavax’s vaccine, mpox, “bird flu”, the ongoing measles outbreak [...]"

youtube.com/watch?v=ejOSXI6oRtI

Continued thread

…As part of his #HHS role, Archer has in recent days posed questions to the #CDC about the advisory cmte recommendations, acc/to the documents & 2 sources.

One recommendation would expand eligibility for #RSV #vaccines made by Pfizer & GSK to #HighRisk adults aged 50-59 from a current threshold age of at least 60 yrs.

In response, Archer asked for more justification of the expansion given what he described as a “possible decline in efficacy with a second dose.”…